Historically, milk thistle, also known as Silybum marianum, has been exploited for the claimed hepatoprotective characteristics that it possesses. Although preclinical research show promise, clinical trials have not always consistently validated these results. Although milk thistle is generally regarded as safe, it may interact with many drugs, especially those processed by the cytochrome P450 system. Those on concomitant drugs, those with mild to severe liver disease, or those with hemochromatosis should exercise care. The currently available evidence on the safety profile and effectiveness of milk thistle is investigated in the present article.
For millennia, people have naturally treated liver problems with milk thistle. In laboratory contexts, silymarin, its active component, has antioxidant, anti-inflammatory, and antifibrotic effects. Transposing these results into practical use has proved difficult, though.
Milk Thistle
Preclinical Evidence
In vitro and animal studies suggest that silymarin can protect liver cells from various toxins, reduce oxidative stress, and modulate immune responses (Flora et al., 1998). These promising results have spurred interest in its therapeutic potential for human liver diseases.​
Clinical Evidence
Despite encouraging preclinical data, clinical trials have yielded mixed outcomes. A systematic review by Rambaldi et al. (2005) analyzed randomized controlled trials assessing milk thistle’s efficacy in liver diseases. The review found no significant decrease in mortality, improvement in liver histology, or consistent changes in liver enzyme levels among patients treated with milk thistle compared to placebo. The authors concluded that the evidence was insufficient to support or refute milk thistle’s efficacy in treating liver diseases.
Safety Profile and Drug Interactions
Milk thistle is generally well-tolerated, with mild gastrointestinal disturbances being the most commonly reported adverse effects (Flora et al., 1998). However, concerns arise regarding its potential to interact with medications metabolized by the cytochrome P450 (CYP) enzyme system. In vitro studies have indicated that silymarin can inhibit certain CYP enzymes, which could theoretically alter the metabolism of concomitant medications (Kroll et al., 2007). Nonetheless, clinical studies have not consistently demonstrated significant interactions. For instance, a study by Kawaguchi-Suzuki et al. (2014) found that milk thistle administration did not significantly affect the activity of major CYP enzymes in healthy volunteers.
Adverse Effects:
Common side effects of milk thistle include gastrointestinal disturbances like diarrhea, nausea, and bloating. Allergic reactions are also possible, especially in individuals sensitive to plants like ragweed, chrysanthemums, marigolds, and daisies.
Women with hormone-sensitive conditions—such as breast, uterine, or ovarian cancers; endometriosis; or uterine fibroids—are advised to avoid using milk thistle due to its potential estrogen-like effects. Impotence in 0.22% of volunteers, though a rare side effect could be implicated to the estrogen like effects.
Our Recommendations:
Healthy people on no meds and without an adverse reaction to Milk thistle have been found to tolerate Milk thistle really well. For those with any medical condition, however, given the present data, those seeking milk thistle supplementation should see medical practitioners, particularly if they use other drugs or have past liver problems. Although milk thistle is safe for overall consumption, its effectiveness in treating liver problems is yet unknown. Patients having moderate to severe liver disease or hemochromatosis should exercise caution since drug interactions and side effects are likely.
Those diagnosed with liver ailments often look for therapeutic methods to help in recovery. Many liver diseases allow for slow improvement with time. As a result, even if these supplements have not been scientifically confirmed to be beneficial, patients may credit their recovery to those they are consuming. This phenomena begs doubts regarding the effectiveness of several supplements, such as milk thistle (Silybum marianum), in the treatment of liver diseases.
Traditionally, milk thistle has been utilized for its allegedly hepatoprotective effects. In laboratory settings, preclinical investigations have found that silymarin, its active component, shows antioxidant, anti-inflammatory, and antifibrotic properties. Translation of these insights into clinical practice has, however, produced conflicting findings. Although it may assist some people reduce liver-related death, a comprehensive review and meta-analysis found that silymarin does not appreciably influence all-cause death in those with cirrhosis. ​​​​​
The natural course of liver diseases, which can improve over time, and the placebo effect—where people report either real or perceived changes in health following a treatment with no therapeutic effect—may help to shape the view of benefit from milk thistle supplements. Based on the present data, milk thistle seems to be safe for general consumption, although its effectiveness in treating liver problems is nonetheless not known. The fundamental problem is that the influence of milk thistle on pharmaceuticals as well as other herbal supplements by means of P450 enzyme system modification causes harmful effects indirectly, therefore overshadowing any possible benefits of milk thistle. The studies only provide half the picture; in actual practice we regularly observe negative effects from other drugs and supplements.
Conclusion
Although milk thistle has promise in preclinical research, there is not consistent evidence of therapeutic benefit. Its good safety profile allows careful use among people looking for possible benefits to their liver. Those with major liver illness or on several drugs should be careful and see doctors before using milk thistle containing supplements, though.
TLDR: Although most of the time Milk thistle is safe if you are not on any drugs, you should definitely check with your doctor if you are currently taking any.
References:
Flora, K., Hahn, M., Rosen, H., & Benner, K. (1998). Milk thistle (Silybum marianum) for the therapy of liver disease. American Journal of Gastroenterology, 93(2), 139-143.
Kawaguchi-Suzuki, M., Frye, R. F., Zhu, H. J., Brinda, B. J., Chavin, K. D., Bernstein, H. J., & Markowitz, J. S. (2014). The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity. Drug Metabolism and Disposition, 42(10), 1611-1616. https://pmc.ncbi.nlm.nih.gov/articles/PMC4164972
Rambaldi, A., Jacobs, B. P., Iaquinto, G., & Gluud, C. (2005). Milk thistle for alcoholic and/or hepatitis B or C liver diseases—a systematic Cochrane hepato-biliary group review with meta-analyses of randomized clinical trials. The American Journal of Gastroenterology, 100(11), 2583-2591.
Read Alternative Medicine articles, click here.
